🎯 check Afatinib (BIBW2992) product page
Afatinib is an irreversible ErbB inhibitor. It affects AKT/ERK signaling pathways, by covalent binding, inhibiting cell growth.
Afatinib (BIBW2992): Mechanism of Action
Afatinib (BIBW2992) MOA：Targeting EGFR/PI3K-AKT Pathway for Non-Small Cell Lung Cancer